Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,761 results that match your search.21,761 results
  • Ned Israelsen and Christopher Sweeney of Knobbe Martens Olson & Bear argue that, when it comes to big pharma's research and development pipeline, the low-hanging fruit has been picked and it's time to tend the orchard
  • Given the richness of Mexico's genetic resources, biopiracy is a serious threat in the country. Osvaldo Amaral of Olivares & Cia examines the existing and proposed legislation to protect local communities
  • The scope of the experimental use exemption is a vital issue for both research-based and generic pharmaceutical companies. Ina Schreiber and Cyra Nargolwalla of Cabinet Plasseraud examine attempts to harmonize the law in Europe, and compare practice in France, Germany and the UK
  • The Canadian government has proposed changes to the regulations governing patented medicines and data exclusivity. David Heller and Adrian Zahl of Ridout & Maybee explain how the reforms will affect the research-based and generic industries
  • Biological resources can provide commercial opportunities but their importance for local communities must also be respected. Sunita K Sreedharan of Anand & Anand examines how India has reconciled conflicting demands in this area
  • The Uniform Dispute Resolution Policy has made it easier for trade mark owners to win the rights to contested domain names. Frequent UDRP panellist Mark Partridge shows how victims of cybersquatting can maximize their chances of success
  • Fabrizio Miazzetto examines the issues litigants should consider when bringing proceedings before the new CTM and CD courts in Alicante and discusses the opportunities for rights owners to forum shop in Europe
  • International harmonization, trend-setting cases and new enforcement strategies are all on the IP menu for 2005. MIP spoke to practitioners worldwide to identify some of the expected events and trends. We also provide an overview of what’s happening where in 2005. James Nurton, Sam Mamudi and Emma Barraclough
  • As part of its wider reform efforts, the USPTO in late 2004 amended the form of its patent interference procedures. Barry Bretschneider and Matthew I Kreeger outline what the little-noticed changes will mean for patent owners
  • After five months of research, MIP can now unveil the IP survey 2005, listing the leading firms in 57 jurisdictions. The first part, published here, provides a guide to the leading patent firms worldwide. James Nurton explains the new methodology and introduces the results